Search company, investor...

Predict your next investment

Angel Investor (Group)
angelinvestorforum.com

Investments

70

Portfolio Exits

10

About Angel Investor Forum

The Angel Investor Forum provides accredited investors with the chance to pool their resources to fund seed-stage opportunities ($100K-$2M) with a particular focus in Connecticut and the Northeast area.

Headquarters Location

222 Pitkin Street Suite 113

East Hartford, Connecticut, 06108,

United States

860.289.0878 x337

Want to inform investors similar to Angel Investor Forum about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Angel Investor Forum News

Founder Update: BIOARRAY Secures Series A Funding

Sep 26, 2017

We are excited to announce that VDC Founder company, BIOARRAY Therapeutics Inc., has gained $600,000 of new funding in the initial closing of the company’s Series A funding. The financing, led by Connecticut Innovations, included participation by the Angel Investor Forum, and Boston Harbor Angels, with additional participation from the City of New Haven/CURE Bioscience grant. BIOARRAY Therapeutics Inc. is a clinical-stage molecular diagnostics company developing and commercializing RNA-based predictive diagnostics for cancer. The new funding comes shortly after election of experienced life-science angel investor, Henry Kay, to BIOARRAY’s Board of Directors last Fall. To learn more about BIOARRY, click here Submit a Comment

Angel Investor Forum Investments

70 Investments

Angel Investor Forum has made 70 investments. Their latest investment was in GlucoGear as part of their Seed on October 10, 2018.

CBI Logo

Angel Investor Forum Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/10/2018

Seed

GlucoGear

$0.25M

Yes

6/29/2017

Seed VC

Lynq

$1.9M

Yes

1

7/16/2015

Unattributed

Delmarva Bancshares

$14M

Yes

1

4/29/2015

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/9/2015

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/10/2018

6/29/2017

7/16/2015

4/29/2015

2/9/2015

Round

Seed

Seed VC

Unattributed

Series A

Seed VC

Company

GlucoGear

Lynq

Delmarva Bancshares

Subscribe to see more

Subscribe to see more

Amount

$0.25M

$1.9M

$14M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

10

10

Angel Investor Forum Portfolio Exits

10 Portfolio Exits

Angel Investor Forum has 10 portfolio exits. Their latest portfolio exit was Respiratory Motion on June 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/1/2022

Acquired

$99M

3

3/28/2022

Merger

$99M

1

10/31/2020

Acq - P2P

$99M

5

10/1/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/14/2019

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/1/2022

3/28/2022

10/31/2020

10/1/2020

8/14/2019

Exit

Acquired

Merger

Acq - P2P

Acquired

Acq - Fin

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

1

5

10

10

Angel Investor Forum Team

2 Team Members

Angel Investor Forum has 2 team members, including current President, Edward Goodwin Ph D.

Name

Work History

Title

Status

Edward Goodwin Ph D

President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Edward Goodwin Ph D

Subscribe to see more

Work History

Title

President

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.